2000: The Year in Device Exits
This article was originally published in Start Up
While investors remain skeptical of device IPOs, and large device firms don't seem as eager as they once did to snap up their smaller counterparts in stock transactions, 2000 did see a relatively healthy number of exits for private device investors, both via IPO and acquisition.
You may also be interested in...
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.
No device-related warning letters were released by the US FDA the week of 19 January.
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.